Abstract: An assembly of the present invention for a syringe includes a piercing needle-attached barrel having a barrel body and a hollow piercing needle fixed to the barrel body and a seal cap for sealing a piercing needle tip. The seal cap has a hollow part and a pierceable part into which the piercing needle tip inserted into the hollow part can be pierced. The seal cap is water vapor permeable and placed in a state in which the piercing needle tip has been pierced into the pierceable part. At least the pierceable part of the seal cap is formed of an elastic material containing silicone rubber as a main material thereof, silicone particles, and a lubricant.

Abstract: A compounds of the formula (I): ##STR1## wherein A represents OH or OC(O)CH.sub.3-n X.sub.n, B represents hydrogen atom, or A and B together represent a bond; R.sup.1 represents hydrogen atom, R.sup.2 represents hydrogen atom, C(Z)CH.sub.3-n X.sub.n or C(Z)NHCH.sub.3-n X.sub.n or R.sup.1 and R.sup.2 together represents (CH.sub.2).sub.m, (CH.sub.2).sub.m-1 C(Z), N(R.sup.3)(CH.sub.2).sub.2 C(Z), (CH.sub.2).sub.m-2 NHC(Z) or (CH.sub.2).sub.m-2 OC(Z) in which X represents fluorine atom, chlorine atom, bromine atom, a methyl group or a methoxy group and n represents 0 or an integer of 1 to 3, Z represents oxygem atom or sulfur atom, m represents an integer of 4 or 5 and R.sup.3 represents hydrogen atom or a methyl group, and pharmacological acceptable salts of the compounds which can form salts, processes therefor and pharmaceutical use of the compounds.